Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 1745783

Words QUALITY OF SCIENCE. QUALITY OF LIFE
Image
Image description
Status registered: Renewal due
Priority date 22 Jul 2015 (Convention)
Classes 1, 5, 42, 44
Kind Word
Dates
Renewal due 12 Jan 2026
Registration advertised / published 16 Jun 2016
Entered on Register 08 Jun 2016
Acceptance advertised / published 31 Mar 2016
Acceptance 21 Mar 2016
Filing 12 Jan 2016
Registered from 12 Jan 2016

Owner Address for service
Dimension Therapeutics, Inc.
Corrs Chambers Westgarth

Goods & Services
Class 1: Chemical and biochemical products in this class; chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo use in gene therapy; chemical products, reagents, and biomolecules used for scientific and medical purposes
Class 5: Pharmaceutical and veterinary preparations; pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders; Gene therapy and phrophylaxis products for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders
Class 42: Scientific and technological services and research and design relating thereto; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; and companion diagnostics and assays services in the field of gene therapy design and delivery
Class 44: Medical services; veterinary services; providing medical services, namely, gene therapy design and delivery services in the field of genetic diseases and disorders, providing medical services, namely, gene therapy design and delivery services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; and pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction

Endorsements

Convention details
Date 22 Jul 2015
Number 86/701332
Country UNITED STATES OF AMERICA
Description Convention priority claimed: 22 July 2015, United States of America, No. 86/701332 in respect of CHEMICAL AND BIOCHEMICAL PRODUCTS FOR USE IN GENE DELIVERY TECHNOLOGY, NAMELY, NUCLEIC ACIDS, INCLUDING CODING AND NON-CODING DEOXYRIBONUCLEIC ACIDS, RIBONUCLEIC ACIDS, PLASMIDS, VECTORS, PROMOTORS, ENHANCERS AND OTHER REGULATORY SEQUENCES, ALL FOR IN-VIVO USE IN GENE THERAPY; CHEMICAL PRODUCTS, REAGENTS, AND BIOMOLECULES USED FOR SCIENTIFIC AND MEDICAL PURPOSES in class 1; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GENETIC DISEASES AND DISORDERS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF LIVER, HEPATOLOGICAL, CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, ENDOCRINE, GASTROINTESTINAL, IMMUNOLOGICAL, DERMATOLOGICAL, INFECTIOUS, INFLAMMATORY, MENOPAUSAL, METABOLIC, AUTOIMMUNE, MUSCULOSKELETAL, NEUROLOGICAL, OPHTHALMOLOGIC, PSYCHIATRIC, RESPIRATORY, UROGENITAL, UROLOGICAL, HEMATOLOGIC, AND FUNGAL AND VIRAL DISEASES AND DISORDERS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, PAIN, DIABETES, DAMAGED SKIN, DAMAGED TISSUE AND ADDICTION; GENE THERAPY AND PROPHYLAXIS PRODUCTS, NAMELY, GENE TRANSFER, REGULATION, MODULATION AND DELIVERY PHARMACEUTICALS FOR THE TREATMENT OF GENETIC DISEASES AND DISORDERS; GENE THERAPY AND PHROPHYLAXIS PRODUCTS FOR THE TREATMENT OF LIVER, HEPATOLOGICAL, CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, ENDOCRINE, GASTROINTESTINAL, IMMUNOLOGICAL, DERMATOLOGICAL, INFECTIOUS, INFLAMMATORY, MENOPAUSAL, METABOLIC, AUTOIMMUNE, MUSCULOSKELETAL, NEUROLOGICAL, OPHTHALMOLOGIC, PSYCHIATRIC, RESPIRATORY, UROGENITAL, UROLOGICAL, HEMATOLOGIC, FUNGAL AND VIRAL DISEASES AND DISORDERS in class 5; BIOMEDICAL AND SCIENTIFIC RESEARCH IN THE FIELDS OF GENOME EDITING, GENE EDITING, GENOME ENGINEERING, GENE MODULATION, GENETIC DISEASES, GENE THERAPY, AND CELL THERAPY; DEVELOPMENT OF PRODUCTS BEING GENETIC THERAPIES AND EFFECTORS TO REGULATE, MODULATE, AND CHARACTERIZE DISEASE STATES; PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF GENE THERAPY; CONDUCTING CLINICAL TRIALS FOR OTHERS IN THE FIELD OF GENE THERAPY DESIGN AND DELIVERY; BIOMEDICAL RESEARCH IN THE FIELD OF GENE THERAPY DESIGN AND DELIVERY; AND COMPANION DIAGNOSTICS AND ASSAYS SERVICES IN THE FIELD OF GENE THERAPY DESIGN AND DELIVERY in class 42; PROVIDING MEDICAL SERVICES, NAMELY, GENE THERAPY DESIGN AND DELIVERY SERVICES IN THE FIELD OF GENETIC DISEASES AND DISORDERS, PROVIDING MEDICAL SERVICES, NAMELY, GENE THERAPY DESIGN AND DELIVERY SERVICES IN THE FIELD OF LIVER, HEPATOLOGICAL, CARDIOVASCULAR, CENTRAL NERVOUS SYSTEM, ENDOCRINE, GASTROINTESTINAL, IMMUNOLOGICAL, DERMATOLOGICAL, INFECTIOUS, INFLAMMATORY, MENOPAUSAL, METABOLIC, AUTOIMMUNE, MUSCULOSKELETAL, NEUROLOGICAL, OPHTHALMOLOGIC, PSYCHIATRIC, RESPIRATORY, UROGENITAL, UROLOGICAL, HEMATOLOGIC, FUNGAL AND VIRAL DISEASES AND DISORDERS; AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, PAIN, DIABETES, DAMAGED SKIN, DAMAGED TISSUE AND ADDICTION in class 44.

Indexing constituents
Word Image